Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 2Prostatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Medulloblastoma 1Glioma 1Carcinoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Filgrastim 4Cyclophosphamide 4Vincristine 3Topotecan 3Melphalan 3Lomustine 3Granulocyte Colony-Stimulating Factor 3Cisplatin 3etoposide phosphate 2Thiotepa 2Temozolomide 2Radiotherapy 2Mesna 2Ifosfamide 2Etoposide 2Carboplatin 2Busulfan 2sonidegib 1sodium thiosulfate 1silmitasertib 1sargramostim 1ribociclib 1poly ICLC 1palbociclib 1omburtamab I-131 1gadobutrol 1gadobenic acid 1bempegaldesleukin 1Yoga 1Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Medulloblastoma × Vaccines × Clear all
NCT02332889 2018-05-04

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

University of Louisville

Phase 1/2 Terminated
1 enrolled 6 charts
CNS

Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡